These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17311669)

  • 1. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 2. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
    Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
    Olsson R
    Lakartidningen; 2002 Mar; 99(12):1325-30. PubMed ID: 11998165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
    Mayo MJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
    [No Abstract]   [Full Text] [Related]  

  • 11. The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.
    Kuiper EM; Hansen BE; Lesterhuis W; Robijn RJ; Thijs JC; Engels LG; Koek GH; Aparicio MN; Kerbert-Dreteler MJ; van Buuren HR;
    Clin Res Hepatol Gastroenterol; 2011 Jan; 35(1):29-33. PubMed ID: 20810227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 13. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 14. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Talwalkar JA; Gossard AA
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
    [No Abstract]   [Full Text] [Related]  

  • 15. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
    Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
    Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
    Poupon R; Chrétien Y; Chazouillères O; Poupon RE
    J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Walker LJ; Newton J; Jones DE; Bassendine MF
    Hepatology; 2009 Jan; 49(1):337-8; author reply 338. PubMed ID: 19035342
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 19. How, why, and when does primary biliary cirrhosis recur after liver transplantation?
    Williams R; Gershwin ME
    Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403
    [No Abstract]   [Full Text] [Related]  

  • 20. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
    Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
    Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.